RIGEL PHARMACEUTICALS INC (RIGL) › Capital ExpendituresRIGEL PHARMACEUTICALS INC (RIGL) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $141.0K2010: $3.56M2011: $2.30M2012: $3.38M2013: $1.22M2014: $413.0K2015: $546.0K2016: $804.0K2017: $164.0K2018: $1.11M2019: $1.46M2020: $1.26M2021: $627.0K2022: $450.0K$450.0K2009Capital Expenditures (USD)2022Fiscal YearCapital ExpendituresChange YoY2022$450.0K-28.2%2021$627.0K-50.3%2020$1.26M-13.3%2019$1.46M+31.6%2018$1.11M+574.4%2017$164.0K-79.6%2016$804.0K+47.3%2015$546.0K+32.2%2014$413.0K-66.2%2013$1.22M-63.8%2012$3.38M+46.6%2011$2.30M-35.3%2010$3.56M+2424.8%2009$141.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share